UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EP294/#363 Phase 1/2 study of galinpepimut-S plus pembrolizumab combination in patients with WT1+ platinum-resistant ovarian cancer in 2nd/3rd line of therapy

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A199-A200

2023

Volltextzugriff (PDF)

Self-conjugate (s,s+d,⋯,s+pd)-core partitions and free Motzkin paths

The Ramanujan journal, 2022-03, Vol.57 (3), p.907-929

2022

Volltextzugriff (PDF)

Immunologic responses in triple-negative breast cancer patients in a randomized phase IIb trial of nelipepimut-S plus trastuzumab versus trastuzumab alone to prevent recurrence

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.556-556

2019

Volltextzugriff (PDF)

Final analysis of nelipepimut-S plus GM-CSF with trastuzumab versus trastuzumab alone to prevent recurrences in high-risk, HER2 low-expressing breast cancer: A prospective, randomized, blinded, multicenter phase IIb trial

Journal of clinical oncology, 2019-03, Vol.37 (8_suppl), p.1-1

2019

Volltextzugriff (PDF)

S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis

Free radical biology & medicine, 2013-08, Vol.61, p.438-452

2013

Volltextzugriff (PDF)

Cyclo‐oxygenase‐2 inhibitors or nonselective NSAID s plus gastroprotective agents: what to prescribe in daily clinical practice?

Alimentary pharmacology & therapeutics, 2013-07, Vol.38 (2), p.178-189

2013

Volltextzugriff (PDF)

A phase II study of sunitinib (S) plus erlotinib (E) in advanced renal carcinoma (RCC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4528-4528

2010

Volltextzugriff (PDF)

Final phase II results of NCI 6981: A phase I/II study of sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e15165-e15165

2011

Volltextzugriff (PDF)

Comparison of Estimated Effects of Air Pollution on Human Mortality Calculated Via S-Plus and SAS

Epidemiology (Cambridge, Mass.), 2009-11, Vol.20, p.S153-S154

2009

Volltextzugriff (PDF)

Air Pollution Concerns Not Changed by S-PLUS Flaw

Science (American Association for the Advancement of Science), 2003-01, Vol.299 (5607), p.665-666

2003

Volltextzugriff (PDF)

Model-based clustering using S-PLUS

International journal of methods in psychiatric research, 2006-01, Vol.15 (3), p.146-156

2006

Volltextzugriff (PDF)

Public health. Air pollution concerns not changed by S-PLUS flaw

Science (American Association for the Advancement of Science), 2003-01, Vol.299 (5607), p.665

2003

Volltextzugriff (PDF)

Different Convergence Parameters Applied to the S-PLUS GAM Function

Epidemiology (Cambridge, Mass.), 2002-11, Vol.13 (6), p.742-742

2002

Volltextzugriff (PDF)

Analyzing Medical Data Using S-PLUS: Brian Everitt, Sophia Rabe-Hesketh. Heidelberg: Springer, 2001, pp. 485, L59.00 (HB) ISBN: 0 387 98862 9. Statistics for Biology and Health, XII. Dietz K, Gail M, Krickeberg K et al. (eds)

International journal of epidemiology, 2003-02, Vol.32 (1), p.167

May, Margaret

2003

Volltextzugriff (PDF)

Sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC): Updated phase I results from a phase I/II trial (NCI 6981)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.16023-16023

2008

Volltextzugriff (PDF)

Analyzing Medical Data Using S-PLUS

International journal of epidemiology, 2003-02, Vol.32 (1), p.167-168

May, Margaret

2003

Volltextzugriff (PDF)

Multidisciplinary data review and analysis to fulfill NIH data sharing requirements via S-Plus server

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P72-P72

2005

Volltextzugriff (PDF)

Phase II study of TS-1 (S) plus cisplatin (P) with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.18070-18070

2007

Volltextzugriff (PDF)

Sorafenib (S) plus gemcitabine (G) for advanced pancreatic cancer (PC): A phase II trial of the University of Chicago Phase II Consortium

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.4608-4608

2007

Volltextzugriff (PDF)

P2-217: Phase II study of TS-1(S) plus cisplatin(P) with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer (NSCLC)

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S658-S658

2007

Volltextzugriff (PDF)

Phase I trial of the multi-drug resistance (MDR) Protein-1 (MRP-1) modulating agent sulindac (S) plus epirubicin (E) in patients (pts) with advanced cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2129-2129

2004

Volltextzugriff (PDF)

Phase I trial of the multi-drug resistance (MDR) Protein-1 (MRP-1) modulating agent sulindac (S) plus epirubicin (E) in patients (pts) with advanced cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2129-2129

2004

Volltextzugriff (PDF)

Surround masking reveals binocular adding and differencing channels

Vision research (Oxford), 2024-06, Vol.219, p.108396-108396, Article 108396

2024

Volltextzugriff (PDF)

Statistical Computing, An Introduction to Data Analysis Using S-Plus/The Statistical Evaluation of Medical Tests for Classification and Prediction/Introductory Biostatistics

Clinical chemistry (Baltimore, Md.), 2003-11, Vol.49 (11), p.1959

Henderson, A Ralph

2003

Volltextzugriff (PDF)

Statistical Software for Microcomputers: S-PLUS 2000

British Journal of Mathematical & Statistical Psychology, 1999-11, Vol.52 (2), p.327-330

Kulinskaya, Elena V

1999

Volltextzugriff (PDF)

1 – 25 von 725.304

Suche als RSS-Feed

Aktive Filter

Publikationsformgovernment_documents

ThemaFemale

KollektionOvid SocietyJournals and Single Titles

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(688.415)
Mit Volltextzugriff
(616.562)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(529.524)
Life Sciences & Biomedicine
(469.094)
Humans
(222.683)
Animals
(126.495)
Biological And Medical Sciences
(111.175)
Male
(62.818)
Fundamental And Applied Biological Sciences. Psychology
(60.564)
Medical Sciences
(57.640)
Oncology
(54.328)
Biochemistry & Molecular Biology
(51.373)
Social Sciences
(49.772)
Biomedical And Life Sciences
(47.794)
Neurosciences & Neurology
(44.201)
Mice
(43.369)
Life Sciences
(41.994)
Proteins
(40.931)
Cell Biology
(39.902)
Physical Sciences
(39.428)
Medicine
(38.763)
Neurosciences
(37.423)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(338.194)
IngentaConnect
(257.709)
EZB Electronic Journals Library
(256.438)
Wiley Online Library Journals Frontfile Complete
(249.120)
Wiley Online Library Full Collection 2018
(188.295)
SpringerLink
(178.090)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(158.058)
IngentaConnect Journals
(146.135)
NUS Single-Journal Subscriptions
(118.724)
Oxford Journals
(45.913)
JSTOR
(40.679)
Elsevier ScienceDirect Journals
(36.945)
EBSCOhost Psychology and Behavioral Sciences Collection
(32.583)
SAGE Publications
(32.416)
Nexis Uni
(32.337)
Springer Nature - Connect here FIRST to enable access
(31.568)
Taylor & Francis Journals Auto-Holdings Collection
(23.653)
Oxford Journals 2020 Medicine
(23.258)
EBSCOhost Business Source Ultimate
(21.875)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Nature
(8.281)
Canadian Journal Of Zoology
(6.527)
Reactions Weekly
(5.951)
Canadian Journal Of Fisheries And Aquatic Sciences
(5.148)
Oncogene
(5.084)
Canadian Journal Of Microbiology
(4.978)
Canadian Journal Of Botany
(4.908)
The Lancet
(4.636)
The New England Journal Of Medicine
(4.374)
Canadian Journal Of Chemistry
(4.292)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

EP294/#363 Phase 1/2 study of galinpepimut-S plus pembrolizumab combination in patients with WT1+ platinum-resistant ovarian cancer in 2nd/3rd line of therapy

Self-conjugate (s,s+d,⋯,s+pd)-core partitions and free Motzkin paths

Immunologic responses in triple-negative breast cancer patients in a randomized phase IIb trial of nelipepimut-S plus trastuzumab versus trastuzumab alone to prevent recurrence

Final analysis of nelipepimut-S plus GM-CSF with trastuzumab versus trastuzumab alone to prevent recurrences in high-risk, HER2 low-expressing breast cancer: A prospective, randomized, blinded, multicenter phase IIb trial

S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis

Cyclo‐oxygenase‐2 inhibitors or nonselective NSAID s plus gastroprotective agents: what to prescribe in daily clinical practice?

A phase II study of sunitinib (S) plus erlotinib (E) in advanced renal carcinoma (RCC)

Final phase II results of NCI 6981: A phase I/II study of sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC)

Comparison of Estimated Effects of Air Pollution on Human Mortality Calculated Via S-Plus and SAS

Air Pollution Concerns Not Changed by S-PLUS Flaw

Model-based clustering using S-PLUS

Public health. Air pollution concerns not changed by S-PLUS flaw

Different Convergence Parameters Applied to the S-PLUS GAM Function

Analyzing Medical Data Using S-PLUS: Brian Everitt, Sophia Rabe-Hesketh. Heidelberg: Springer, 2001, pp. 485, L59.00 (HB) ISBN: 0 387 98862 9. Statistics for Biology and Health, XII. Dietz K, Gail M, Krickeberg K et al. (eds)

Sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC): Updated phase I results from a phase I/II trial (NCI 6981)

Analyzing Medical Data Using S-PLUS

Multidisciplinary data review and analysis to fulfill NIH data sharing requirements via S-Plus server

Phase II study of TS-1 (S) plus cisplatin (P) with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer (NSCLC)

Sorafenib (S) plus gemcitabine (G) for advanced pancreatic cancer (PC): A phase II trial of the University of Chicago Phase II Consortium

P2-217: Phase II study of TS-1(S) plus cisplatin(P) with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer (NSCLC)

Phase I trial of the multi-drug resistance (MDR) Protein-1 (MRP-1) modulating agent sulindac (S) plus epirubicin (E) in patients (pts) with advanced cancer

Phase I trial of the multi-drug resistance (MDR) Protein-1 (MRP-1) modulating agent sulindac (S) plus epirubicin (E) in patients (pts) with advanced cancer

Surround masking reveals binocular adding and differencing channels

Statistical Computing, An Introduction to Data Analysis Using S-Plus/The Statistical Evaluation of Medical Tests for Classification and Prediction/Introductory Biostatistics

Statistical Software for Microcomputers: S-PLUS 2000

Aktive Filter

Suchergebnisse filtern